Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Multi-site evaluation of the LN34 pan-lyssavirus real-time RT-PCR assay for post-mortem rabies diagnostics.

Gigante CM, Dettinger L, Powell JW, Seiders M, Condori REC, Griesser R, Okogi K, Carlos M, Pesko K, Breckenridge M, Simon EMM, Chu MYJV, Davis AD, Brunt SJ, Orciari L, Yager P, Carson WC, Hartloge C, Saliki JT, Sanchez S, Deldari M, Hsieh K, Wadhwa A, Wilkins K, Peredo VY, Rabideau P, Gruhn N, Cadet R, Isloor S, Nath SS, Joseph T, Gao J, Wallace R, Reynolds M, Olson VA, Li Y.

PLoS One. 2018 May 16;13(5):e0197074. doi: 10.1371/journal.pone.0197074. eCollection 2018.

2.

Mediation effect of beliefs about pleasure and emotional experience between social anhedonia and prediction of pleasant events.

Hu HX, Chu MY, Yang Y, Wang LL, Zhang RT, Lui SSY, Cheung EFC, Chan RCK.

Psychiatry Res. 2018 Jun;264:39-45. doi: 10.1016/j.psychres.2018.03.070. Epub 2018 Mar 27.

PMID:
29626830
3.

Pleasure Experience and Emotion Expression in Patients with Schizophrenia.

Chu MY, Li X, Lv QY, Yl ZH, Cheung EFC, Chan RCK.

Shanghai Arch Psychiatry. 2017 Oct 25;29(5):268-276. doi: 10.11919/j.issn.1002-0829.217072.

4.

Neurological soft signs precede the onset of schizophrenia: a study of individuals with schizotypy, ultra-high-risk individuals, and first-onset schizophrenia.

Chan RCK, Cui HR, Chu MY, Zhang TH, Wang Y, Wang Y, Li Z, Lui SSY, Wang JJ, Cheung EFC.

Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):49-56. doi: 10.1007/s00406-017-0828-4. Epub 2017 Jul 31.

PMID:
28761988
5.

Prominent Vascularization Capacity of Mesenchymal Stem Cells in Collagen-Gold Nanocomposites.

Hsieh SC, Chen HJ, Hsu SH, Yang YC, Tang CM, Chu MY, Lin PY, Fu RH, Kung ML, Chen YW, Yeh BW, Hung HS.

ACS Appl Mater Interfaces. 2016 Oct 26;8(42):28982-29000. doi: 10.1021/acsami.6b09330. Epub 2016 Oct 13.

PMID:
27714998
6.

Patterns and Etiologies of Uveitis at a Tertiary Referral Center in Taiwan.

Chen SC, Chuang CT, Chu MY, Sheu SJ.

Ocul Immunol Inflamm. 2017;25(sup1):S31-S38. doi: 10.1080/09273948.2016.1189577. Epub 2016 Jul 27.

PMID:
27463023
7.

The treatment of nursing home-acquired pneumonia using a medically intensive Hospital in the Home service.

Montalto M, Chu MY, Ratnam I, Spelman T, Thursky K.

Med J Aust. 2015 Dec 14;203(11):441-2.

PMID:
26654613
8.

Effect of RAGE polymorphisms on susceptibility to and severity of osteoarthritis in a Han Chinese population: a case-control study.

Yang HY, Chuang SY, Fang WH, Huang GS, Wang CC, Huang YY, Chu MY, Lin C, Su W, Chen CY, Yang YT, Su SL.

Genet Mol Res. 2015 Sep 25;14(3):11362-70. doi: 10.4238/2015.September.25.3.

9.

The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients.

Trubiano JA, Leung VK, Chu MY, Worth LJ, Slavin MA, Thursky KA.

Antimicrob Resist Infect Control. 2015 Jun 1;4:23. doi: 10.1186/s13756-015-0063-6. eCollection 2015.

10.

In vitro study of a novel nanogold-collagen composite to enhance the mesenchymal stem cell behavior for vascular regeneration.

Hung HS, Chang CH, Chang CJ, Tang CM, Kao WC, Lin SZ, Hsieh HH, Chu MY, Sun WS, Hsu SH.

PLoS One. 2014 Aug 5;9(8):e104019. doi: 10.1371/journal.pone.0104019. eCollection 2014.

11.

Regulation of human endothelial progenitor cell maturation by polyurethane nanocomposites.

Hung HS, Yang YC, Lin YC, Lin SZ, Kao WC, Hsieh HH, Chu MY, Fu RH, Hsu SH.

Biomaterials. 2014 Aug;35(25):6810-21. doi: 10.1016/j.biomaterials.2014.04.076. Epub 2014 May 14.

PMID:
24836305
12.

Biocompatibility and favorable response of mesenchymal stem cells on fibronectin-gold nanocomposites.

Hung HS, Tang CM, Lin CH, Lin SZ, Chu MY, Sun WS, Kao WC, Hsien-Hsu H, Huang CY, Hsu SH.

PLoS One. 2013 Jun 24;8(6):e65738. doi: 10.1371/journal.pone.0065738. Print 2013.

13.

Mediation of the migration of endothelial cells and fibroblasts on polyurethane nanocomposites by the activation of integrin-focal adhesion kinase signaling.

Hung HS, Chu MY, Lin CH, Wu CC, Hsu SH.

J Biomed Mater Res A. 2012 Jan;100(1):26-37. doi: 10.1002/jbm.a.33224. Epub 2011 Oct 4.

PMID:
21972215
14.

Carbapenemases in enterobacteria, Hong Kong, China, 2009.

Chu YW, Tung VW, Cheung TK, Chu MY, Cheng N, Lai C, Tsang DN, Lo JY.

Emerg Infect Dis. 2011 Jan;17(1):130-2. doi: 10.3201/eid1701.101443. No abstract available.

15.

Epidemiological analysis of Streptococcus pyogenes infections in Hong Kong.

Chan JC, Chu YW, Chu MY, Cheung TK, Lo JY.

Pathology. 2009;41(7):681-6. doi: 10.3109/00313020903257723.

PMID:
20001348
16.

Varibaculum cambriense infections in Hong Kong, China, 2006.

Chu YW, Wong CH, Chu MY, Cheung CP, Cheung TK, Tse C, Luk WK, Lo JY.

Emerg Infect Dis. 2009 Jul;15(7):1137-9. doi: 10.3201/eid1507.081291. No abstract available.

17.

[A comparison of accuracy in measuring cardiac output and cardiac index using thermodilution method and USCOM 1A after coronary artery bypass grafting].

Chu MY, Li CS, An XG.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Jun;21(6):367-8. Chinese. No abstract available.

18.

OXA-23-type imipenem resistance in Acinetobacter baumannii in Hong Kong.

Chu YW, Cheung TK, Chu MY, Lo JY, Dijkshoorn L.

Int J Antimicrob Agents. 2009 Sep;34(3):285-6. doi: 10.1016/j.ijantimicag.2009.03.010. Epub 2009 Apr 24. No abstract available.

PMID:
19394202
19.

Resistance to tetracycline, erythromycin and clindamycin in Streptococcus suis serotype 2 in Hong Kong.

Chu YW, Cheung TK, Chu MY, Tsang VY, Fung JT, Kam KM, Lo JY.

Int J Antimicrob Agents. 2009 Aug;34(2):181-2. doi: 10.1016/j.ijantimicag.2009.01.007. Epub 2009 Apr 19. No abstract available.

PMID:
19380213
20.

Panton-Valentine leukocidin-positive meticillin-resistant Staphylococcus aureus in the community in Hong Kong.

Cheung TK, Chu YW, Chu MY, Tsang VY, Lo JY.

J Med Microbiol. 2008 Nov;57(Pt 11):1440-3. doi: 10.1099/jmm.0.2008/004382-0. No abstract available.

PMID:
18927429
21.

Novel truncating mutations of the CHM gene in Chinese patients with choroideremia.

Yip SP, Cheung TS, Chu MY, Cheung SC, Leung KW, Tsang KP, Lam ST, To CH.

Mol Vis. 2007 Nov 27;13:2183-93.

PMID:
18087237
22.

Rapid pulsed-field gel electrophoresis protocol for subtyping of Streptococcus suis serotype 2.

Luey CK, Chu YW, Cheung TK, Law CC, Chu MY, Cheung DT, Kam KM.

J Microbiol Methods. 2007 Mar;68(3):648-50. Epub 2006 Dec 8.

PMID:
17157941
23.
24.

Denaturing HPLC for high-throughput screening of rifampicin-resistant Mycobacterium tuberculosis isolates.

Yip CW, Leung KL, Wong D, Cheung DT, Chu MY, Tang HS, Kam KM.

Int J Tuberc Lung Dis. 2006 Jun;10(6):625-30.

PMID:
16776449
25.

Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong.

Cheung TK, Chu YW, Chu MY, Ma CH, Yung RW, Kam KM.

J Antimicrob Chemother. 2005 Sep;56(3):586-9. Epub 2005 Jul 20.

PMID:
16033804
26.

Genetic relatedness and quinolone resistance of Campylobacter jejuni strains isolated in 2002 in Hong Kong.

Chu YW, Chu MY, Luey KY, Ngan YW, Tsang KL, Kam KM.

J Clin Microbiol. 2004 Jul;42(7):3321-3.

27.

Use of developmental language scales in Chinese children.

Au YL, Ma KM, Sy WM, Lee WC, Leung LS, Au Yeung YC, Chu MY, Chung CK, Ho PK, Lau WL, Law PK, Siu PY, Tse KS, Wong V.

Brain Dev. 2004 Mar;26(2):127-9.

PMID:
15036432
28.
29.

Inactivation of SSI-1, a JAK/STAT inhibitor, in human hepatocellular carcinomas, as revealed by two-dimensional electrophoresis.

Nagai H, Kim YS, Lee KT, Chu MY, Konishi N, Fujimoto J, Baba M, Matsubara K, Emi M.

J Hepatol. 2001 Mar;34(3):416-21.

PMID:
11322203
31.

Predictive sensitivity of human cancer cells in vivo using semipermeable polysulfone fibers.

Chu MY, Lipsky MH, Yee LK, Epstein J, Whartenby KA, Freeman S, Chen TM, Chu E, Forman EN, Calabresi P.

Pharmacology. 1998 Jun;56(6):318-26.

PMID:
9654219
32.

Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.

Pizzorno G, Yee L, Burtness BA, Marsh JC, Darnowski JW, Chu MY, Chu SH, Chu E, Leffert JJ, Handschumacher RE, Calabresi P.

Clin Cancer Res. 1998 May;4(5):1165-75.

33.

Benzylacyclouridine enhances 5-fluorouracil cytotoxicity against human prostate cancer cell lines.

Yee LK, Chu E, Pan BC, Chu SH, Chen TM, Lipsky MH, Chu MY, Calabresi P.

Pharmacology. 1998 Feb;56(2):80-91.

PMID:
9494066
34.

Inhibition of growth factor mitogenicity and growth of tumor cell xenografts by a sulfonated distamycin A derivative.

Finch PW, Yee LK, Chu MY, Chen TM, Lipsky MH, Maciag T, Friedman S, Epstein MH, Calabresi P.

Pharmacology. 1997 Dec;55(6):269-78.

PMID:
9413855
35.

Expression of mRNA for brain-derived neurotrophic factor in the dorsal root ganglion following peripheral inflammation.

Cho HJ, Kim SY, Park MJ, Kim DS, Kim JK, Chu MY.

Brain Res. 1997 Feb 28;749(2):358-62.

PMID:
9138740
36.
37.

Cell culture of the mucinous variant of human colorectal carcinoma.

Tibbetts LM, Chu MY, Vezeridis MP, Miller PG, Tibbetts LL, Poisson MH, Camara PD, Calabresi P.

Cancer Res. 1988 Jul 1;48(13):3751-9.

38.

Inhibitors of purine nucleoside phosphorylase: effects of 9-deazapurine ribonucleosides and synthesis of 5'-deoxy-5'-iodo-9-deazainosine.

Stoeckler JD, Ryden JB, Parks RE Jr, Chu MY, Lim MI, Ren WY, Klein RS.

Cancer Res. 1986 Apr;46(4 Pt 1):1774-8.

39.

Differential characteristics of two newly established human breast carcinoma cell lines.

Chu MY, Hagerty MG, Wiemann MC, Tibbetts LM, Sato S, Cummings FJ, Bogaars HA, Leduc EH, Calabresi P.

Cancer Res. 1985 Mar;45(3):1357-66.

40.
41.
42.

9-Deazaadenosine--a new potent antitumor agent.

Chu MY, Zuckerman LB, Sato S, Crabtree GW, Bogden AE, Lim MI, Klein RS.

Biochem Pharmacol. 1984 Apr 15;33(8):1229-34.

PMID:
6712733
43.

Differential responses to x-irradiation of subpopulations of two heterogeneous human carcinomas in vitro.

Leith JT, Dexter DL, DeWyngaert JK, Zeman EM, Chu MY, Calabresi P, Glicksman AS.

Cancer Res. 1982 Jul;42(7):2556-61.

44.
45.

Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.

Turcotte JG, Srivastava SP, Steim JM, Calabresi P, Tibbetts LM, Chu MY.

Biochim Biophys Acta. 1980 Sep 8;619(3):619-31.

PMID:
7459369
46.

Chemotherapy of cell-line-derived human colon carcinomas in mice immunosuppressed with antithymocyte serum.

Tibbetts LM, Chu MY, Hager JC, Dexter DL, Calabresi P.

Cancer. 1977 Nov;40(5 Suppl):2651-9.

PMID:
303540
47.

A phospholipid derivative of cytosine arabinoside and its conversion to phosphatidylinositol by animal tissue.

Raetz CR, Chu MY, Srivastava S, Turcotte JG.

Science. 1977 Apr 15;196(4287):303-5.

PMID:
191910
48.

Effects of 5-fluorodeoxyuridine on cell viability and uptake of deoxycytidine and (3H)cytosine arabinoside in L5178Y cells.

Chu MY, Hoovis ML, Fischer GA.

Biochem Pharmacol. 1976 Feb 1;25(3):355-7. No abstract available.

PMID:
131557
49.

Synthesis and cytotoxicity of 6-selenopurine arabinoside and related compounds.

Chu SH, Shiue CY, Chu MY.

J Pharm Sci. 1975 Aug;64(8):1343-6.

PMID:
1171219
50.

Supplemental Content

Support Center